Associate Director, Clinical Data Management Revolution Medicines, Inc.Associate Director, Clinical Data ManagementRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Associate Director, Clinical Regulatory Denali TherapeuticsAssociate Director, Clinical RegulatorySouth San Francisco, CA$171,000–$223,000 / yearDevelops, manages, and mentors junior regulatory professionals and contributes to creating a culture regulatory innovation and excellence; leads direct report(s), if applicable, through annual goal setting, growth planning, adherence to company policies, maintains training compliance and provides ongoing feedback on growth, development and areas of improvement. Key Accountabilities/Core Job Responsibilities: Accountable for developing regulatory strategy for complex development programs; leads project teams in implementing and delivering the regulatory strategy across multiple programs/indications and/or programs of increasing complexity.
Director, Clinical Regulatory Denali Therapeutics IncDirector, Clinical RegulatorySouth San Francisco, CA$211,000–$258,667 / yearKey Accountabilities/Core Job Responsibilities: • Developing and implementing regulatory strategy for complex development programs, leading project teams in implementing and delivering the regulatory strategy across multiple programs/indications and/or programs of increasing complexity • Participating in cross-functional teams to provide regulatory feedback and support, proactively assessing and communicating potential risks and mitigation opportunities • Overseeing and directly leading global Health Authority interactions, independently executing preparation, submission, and maintenance of regulatory applications, including initial applications, routine amendments, annual reports, IND safety reports, and correspondence with global Health Authorities • Partnering with external vendors in support of regulatory document preparation and submission • Leading and executing non-project regulatory activities • Maintaining up-to-date knowledge of the regulatory landscape, regulations, and guidelines and for developing thoughtful, data-driven strategies for influencing the regulatory landscape • Complying with relevant governing laws, regulations, guidelines, and Denali SOPs • Recruiting, developing, managing, and mentoring regulatory professionals; contributing to creating a culture of regulatory innovation and excellence; leading direct report(s), if applicable, through annual goal setting, growth planning, adherence to company policies, training compliance and for providing ongoing feedback on growth, development and areas of improvement. The Director, Clinical Regulatory, is accountable for leading and overseeing global Health Authority interactions, project team support, regulatory intelligence activities, and proposing and implementing department initiatives in our drive to defeat neurodegeneration.
Associate Director, Clinical Regulatory Denali Therapeutics IncAssociate Director, Clinical RegulatorySouth San Francisco, CA$215,544–$260,822 / yearKey Accountabilities/Core Job Responsibilities: • Accountable for developing regulatory strategy for complex development programs; leads project teams in implementing and delivering the regulatory strategy across multiple programs/indications and/or programs of increasing complexity • Responsible for identifying regulatory risk and mitigation in support of development plans • Accountable for overseeing and directly leading global Health Authority interactions • Independently executes preparation, submission, and maintenance of regulatory applications, including initial applications, routine amendments, annual reports, IND safety reports, and correspondence with global Health Authorities • Participates in cross-functional teams, providing regulatory feedback and support • Partners with external vendors in support of regulatory document preparation and submission • Maintains up-to-date knowledge of the regulatory landscape, regulations, and guidelines • Identifies and maintains leadership/ownership of non-project activities • Complies with relevant governing laws, regulations, guidelines, and Denali SOPs • Develops, manages, and mentors junior regulatory professionals and contributes to creating a culture regulatory innovation and excellence; leads direct report(s), if applicable, through annual goal setting, growth planning, adherence to company policies, maintains training compliance and provides ongoing feedback on growth, development and areas of improvement. Denali is founded on the collaboration of leading scientists, industry experts, and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
Associate Director, Clinical Data Management Structure Therapeutics IncAssociate Director, Clinical Data ManagementSouth San Francisco, CA$180,000–$220,000 / yearThe companys platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. The AD serves as primary DM contact to collaborate closely with cross-functional teams, including Clinical Operations, Biostatistics, Clinical Development and Regulatory Affairs, to ensure that data management activities align with the overall clinical development strategy and regulatory requirements.
Director, Clinical Science Sutter HealthDirector, Clinical ScienceLivermore, CA$204,464–$327,142.40 / yearThe position is responsible for the overall clinical quality of testing, development of new tests and test procedures, and verification in accordance with federal requirements under CLIA-88, College of American Pathologists (CAP), the State of California, and any other related regulatory or accrediting body affecting clinical activities of the laboratory. Responsible for ensuring that laboratory services contribute positively to high value medical care and disease prevention through service excellence, analytical accuracy, cost effectiveness, and high value financial performance.
Senior Director, Clinical Development BridgeBio Pharma IncSenior Director, Clinical DevelopmentSan Francisco, CA$340,000–$375,000 / yearThe final salary offered to a successful candidate will depend on several factors that may include but are not limited to the type and length of experience within the job, type, and length of experience within the industry, educational background, location of residence and performance during the interview process. Skill Development & Career Paths: People are part of our growth and success story - from discovery to active drug trials and FDA pipelines, there are endless opportunities for skill development and internal mobility.
Clinical Supply Chain Director Exelixis IncClinical Supply Chain DirectorAlameda, CA$164,500–$234,500 / yearOversees activities relating to the labeling, packaging, and distribution plans for each study (e.g., bulk drug products, matching placebo, PK/PD samples, etc.) based on protocol requirements and factors such as regulatory requirements, blinding concerns, ease of handling by the sites and patients, and patient compliance. EDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education/Experience: BS/BA degree in related discipline and a minimum of thirteen years of related experience; or, MS/MA degree in related discipline and a minimum of eleven years of related experience; or, PhD in related discipline and a minimum of eight years of related experience; or, Equivalent combination of education and experience.
Senior Director, Clinical Operations Compliance Management (Gcp/Biotechnology/Oncology) Exelixis Inc.Senior Director, Clinical Operations Compliance Management (Gcp/Biotechnology/Oncology)Alameda, CA$246,000–$349,500 / yearThe Senior Director of COCM is a key partner with our Quality Assurance team and other functional groups (including Clinical Development, Data Management, etc.) and is responsible for supporting inspection readiness activities, driving cross-study consistency in study execution and compliance with governing functional procedures and processes, and escalation of identified operational issues within development and of identified quality issues to QA. EDUCATION/EXPERIENCE/KNOWLEDGE & SKILLS: Education: Bachelor's degree in related discipline and a minimum of 15 years of related experience; or, Master's degree in related discipline and a minimum of 13 years of related experience; or, Doctoral degree in related discipline and a minimum of 12 years of related experience; or, Equivalent combination of education and experience.
Director, Clinical & Medical Strategic Planning & Management - Job ID: 1911 Ascendis PharmaDirector, Clinical & Medical Strategic Planning & Management - Job ID: 1911Palo Alto, CA$220,000–$230,000 / yearThe remit of the Director, Clinical & Medical Strategic Planning & Management is to maximize productivity and efficiency of team members across Endocrine & Rare Disease Medical Sciences (ERDMS) by providing structure, visibility, and decision-making support. As a member of the ERDMS leadership team, this team member will facilitate efforts in the design and execution of clinical development plans, and medical evidence generation plans, in alignment with Ascendis Pharma’s purpose, values, vision, and priorities.
Director Clinical Pharmacology & DMPK Alumis IncDirector Clinical Pharmacology & DMPKSouth San Francisco, CA$200,000–$240,000 / yearAlumis is seeking a Director of Clinical Pharmacology & DMPK to drive clinical pharmacology strategy and PK/PD modeling for our small-molecule programs in immune-mediated diseases. Specific responsibilities include but are not limited to: Lead clinical pharmacology strategy, dose selection, and PK/PD and biomarker planning across early and late-stage programs.
Senior Director of Clinical Nutrition Services Stanford Health CareSenior Director of Clinical Nutrition ServicesPalo Alto, CA$94.35–$125.03 / hourLeads the expansion of inpatient, outpatient nutrition services, and virtual nutrition programs while driving innovation and new care models including digital health, population health nutrition, and specialty nutrition programs (i.e., oncology, transplant, metabolic health, and other chronic diseases). The Senior Director partners with other senior clinical leaders, physician leaders, population health teams, and other executives to ensure nutrition is embedded in SHC's mission for exceptional patient care, education, and research.
Senior Manager/Director Clinical Operations Lycia Therapeutics IncSenior Manager/Director Clinical OperationsSouth San Francisco, CARemote$180,000–$198,000 / yearAbility to manage in a consensus environment through teamwork, trust and shared expectations, influencing strategic direction of complex global clinical operations issues, solicit information, listen well, persuade others, make important decisions and shape outcomes. Build, develop and train internal staff and external vendors, structure department for enhancing efficiency, and create a highly engaged work environment for attracting and retaining highly qualified clinical operations professionals.
Director Clinical Pharmacology & Dmpk Alumis Inc.Director Clinical Pharmacology & DmpkSouth San Francisco, CA$200,000–$240,000 / yearAlumis is seeking a Director of Clinical Pharmacology & DMPK to drive clinical pharmacology strategy and PK/PD modeling for our small-molecule programs in immune-mediated diseases. Specific responsibilities include but are not limited to: Lead clinical pharmacology strategy, dose selection, and PK/PD and biomarker planning across early and late-stage programs.
VP/Senior Director, Clinical Operations NewLimit IncVP/Senior Director, Clinical OperationsSouth San Francisco, CALearn more at: https://www.newlimit.com/careers *This compensation and benefits information is based on Company''s good faith estimate as of the date of publication and may be modified in the future. Disentangle the inevitable operational challenges that arise in trial execution - debugging recruitment, cross-border logistics, regulatory compliance, and staffing.
Director, Clinical Quality Assurance GCP Eikon Therapeutics IncDirector, Clinical Quality Assurance GCPMillbrae, CA$204,000–$246,750 / yearEikon's discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets. Lead quality management system (QMS) assessment for service providers and collaborate closely with Clinical Development Vendor Oversight team to ensure service provider qualification process is robust and timely.
Senior/Executive Medical Director, Medical Affairs and Clinical Development– Allergy/Gastroenterology AllakosSenior/Executive Medical Director, Medical Affairs and Clinical Development– Allergy/GastroenterologyRedwood City, CaliforniaSenior/Executive Medical Director, Medical Affairs and Clinical Development– Allergy/Gastroenterology Allakos Inc. is a clinical-stage company developing therapeutic antibodies for inhibitory receptors on the surface of immune effector cells involved in allergic, inflammatory and proliferative diseases. In addition, the Senior/Executive Medical Director will play a key role in generating and communicating medical evidence with external stakeholders and will be expected to be a team player with well-developed skills for gaining the cooperation of others and ensuring effective communication among team members.
Vp/Senior Director, Clinical Operations NewLimitVp/Senior Director, Clinical OperationsSouth San Francisco, CALearn more at: https://www.newlimit.com/careers *This compensation and benefits information is based on Company's good faith estimate as of the date of publication and may be modified in the future. Disentangle the inevitable operational challenges that arise in trial execution - debugging recruitment, cross-border logistics, regulatory compliance, and staffing.
Associate Director, Clinical Educator, Sickle Cell Disease (West Zone) - Remote Agios PharmaceuticalsAssociate Director, Clinical Educator, Sickle Cell Disease (West Zone) - RemoteSan Jose, CARemote$153,541–$230,312 / yearThe current base salary range for this position is expected to be between $153,541 and $230,312 annualized; final salary will be determined based on various factors including, but not limited to, years of relevant experience, job knowledge, skills and proficiency, degree/education, and internal comparators. The Regional Agios Clinical Educator Manager is a unique leadership opportunity, providing day to day oversight of 5-7 Agios Clinical Educators (ACEs) who interact directly with patients and healthcare professionals.
Associate Medical Director, Clinical Development - Job ID: 1912, 1913, 1914 Ascendis PharmaAssociate Medical Director, Clinical Development - Job ID: 1912, 1913, 1914Palo Alto, CA$255,000–$265,000 / yearGuided by our core values of Patients, Science, and Passion, we use our TransCon® drug development platform to fulfill our mission of developing new and potentially best-in-class therapies to address unmet medical needs. Presentation of candidates without written permission from the Ascendis Pharma Inc Human Resources team (specifically from: Talent Acquisition Partner or Human Resources Director) is not allowed.
Associate Director, Clinical Development Mirum PharmaceuticalsAssociate Director, Clinical DevelopmentFoster City, CaliforniaThe Associate Director, Clinical Development will be responsible for supporting clinical trial related activities for Brelovitug, a key asset in Phase 3, on a cross-functional team of internal and external experts, investigators and government agencies. Activities include but are not limited to drafting key clinical trial and program-level documents, protocol development, support study startup, recruitment, ongoing clinical development management, and closeout as appropriate.
Associate Director, Biostatistics Clinical Late Stage Revolution Medicines IncAssociate Director, Biostatistics Clinical Late StageRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Clinical Biomarker Development Revolution Medicines IncAssociate Director, Clinical Biomarker DevelopmentRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: The Associate Director in Clinical Biomarker Development team, within Translational Medicine will play a key role in the design, execution, and interpretation of clinical biomarker strategies across Revolution Medicine's oncology pipeline.
Director, Clinical Pharmacology Arcus Biosciences IncDirector, Clinical PharmacologyHayward, CARemote$245,000–$260,000 / yearAt Arcus, the Director, Clinical Pharmacology (CP) functions as the Clinical Pharmacology (CP) team representative at the project teams for small molecule and biotherapeutics in Phase 1-3 of clinical development and is responsible for supporting all clinical pharmacology-related activities. This includes design and execution of clinical pharmacology studies, design of clinical pharmacology portion of other clinical studies, hands-on analysis and reporting of data, and communication of data and analysis reports in regulatory documents and meetings.
Associate Director, Clinical Data Management Revolution Medicines IncAssociate Director, Clinical Data ManagementRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Associate Director, Clinical Quality Assurance Revolution Medicines IncAssociate Director, Clinical Quality AssuranceRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Senior Clinical Operations Asset Director (Oncology) Genentech IncSenior Clinical Operations Asset Director (Oncology)South San Francisco, CA$215,000–$399,400 / yearThe Opportunity: As a Senior Clinical Operations Asset Director, you will provide strategic leadership across one or more development assets spanning solid tumors and hematologic malignancies, helping shape Disease Area strategy and the future of Clinical Operations. Our team provides strategic operational leadership that shapes development plans, drives execution excellence, and enables high-quality, efficient clinical trials.
Senior Clinical Operations Asset Director (Immunology, Neurology, Ophthalmology, and CVRM) Genentech IncSenior Clinical Operations Asset Director (Immunology, Neurology, Ophthalmology, and CVRM)South San Francisco, CA$215,000–$399,400 / yearThe Opportunity: As a Senior Clinical Operations Asset Director, you will provide strategic leadership across one or more development assets in Immunology, Neurology, Ophthalmology, and/or CVRM (Cardiovascular, Renal & Metabolism) while helping shape disease area strategy and the future of Clinical Operations. Our team provides strategic operational leadership that shapes development plans, drives execution excellence, and enables high-quality, efficient clinical trials.
Director, Clinical Data Management Revolution Medicines IncDirector, Clinical Data ManagementRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Senior Director, Clinical Data Management Revolution Medicines IncSenior Director, Clinical Data ManagementRedwood City, CA$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: The Senior Director of Clinical Data Management provides high-level leadership for data management functions within clinical research, focusing on strategic development, operational execution, and regulatory compliance to ensure data integrity for clinical trials.
Associate Director, Clinical Operations Compliance & Training Revolution Medicines IncAssociate Director, Clinical Operations Compliance & TrainingRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Associate Director, Clinical Data Management Revolution MedicinesAssociate Director, Clinical Data ManagementRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Associate Director, Biostatistics Clinical Late Stage Revolution MedicinesAssociate Director, Biostatistics Clinical Late StageRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Director, Clinical Data Management Revolution MedicinesDirector, Clinical Data ManagementRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Associate Director, Clinical Quality Assurance Revolution MedicinesAssociate Director, Clinical Quality AssuranceRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Senior Director, Clinical Data Management Revolution MedicinesSenior Director, Clinical Data ManagementRedwood City, California$244,000–$305,000 / yearThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Senior Director of Clinical Data Management provides high-level leadership for data management functions within clinical research, focusing on strategic development, operational execution, and regulatory compliance to ensure data integrity for clinical trials.
Associate Director, Clinical Operations Compliance & Training Revolution MedicinesAssociate Director, Clinical Operations Compliance & TrainingRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company’s R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Director, Clinical Pharmacology Arcus Biosciences, Inc.Director, Clinical PharmacologyBrisbane, CARemote$245,000–$260,000 / yearAt Arcus, the Director, Clinical Pharmacology (CP) functions as the Clinical Pharmacology (CP) team representative at the project teams for small molecule and biotherapeutics in Phase 1-3 of clinical development and is responsible for supporting all clinical pharmacology-related activities. This includes design and execution of clinical pharmacology studies, design of clinical pharmacology portion of other clinical studies, hands-on analysis and reporting of data, and communication of data and analysis reports in regulatory documents and meetings.
Associate Director, Clinical Biomarker Development Revolution MedicinesAssociate Director, Clinical Biomarker DevelopmentRedwood City, CaliforniaThe company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Associate Director in Clinical Biomarker Development team, within Translational Medicine will play a key role in the design, execution, and interpretation of clinical biomarker strategies across Revolution Medicine’s oncology pipeline.
Associate Director, Clinical Development Mirum Pharmaceuticals IncAssociate Director, Clinical DevelopmentFoster City, CAThe Associate Director, Clinical Development will be responsible for supporting clinical trial related activities for Brelovitug, a key asset in Phase 3, on a cross-functional team of internal and external experts, investigators and government agencies. Activities include but are not limited to drafting key clinical trial and program-level documents, protocol development, support study startup, recruitment, ongoing clinical development management, and closeout as appropriate.
Senior Director, Clinical Development Delfi DiagnosticsSenior Director, Clinical DevelopmentPalo Alto, CA$260,000–$320,000 / yearDirector, Clinical Development provides leadership across DELFI's clinical study portfolio, working closely with senior leadership and cross-functional teams including R&D, medical, quality, and regulatory. DELFI Diagnostics' platform relies on fragmentomics - the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments.
Director, Clinical FP&A BridgeBio Pharma IncDirector, Clinical FP&ASan Francisco, CA$165,000–$217,000 / yearClinical Study Financial Intelligence: Analyze clinical trial expense variances against study operational metrics (e.g., enrollment rates, site activations, protocol amendments, vendor activity) to determine whether variances are temporary in nature or reflect permanent, structural changes to the cost profile of a study. Partner with Clinical Operations study managers to understand study plan pivots, enrollment challenges, vendor performance issues, and other factors driving financial deviations; synthesize this context into clear assessments for the Director and senior leadership.
Senior Director, Clinical Science Ideaya Biosciences IncSenior Director, Clinical ScienceSouth San Francisco, CA$276,000–$341,000 / yearIn addition to study level activities, the Director/Senior Director will participate in program level activities including authoring/reviewing safety and efficacy summaries, clinical overviews, investigator brochures, risk management plans, periodic safety updates and clinical sections of product labels. Non-Solicitation Policy and Notice to Agencies and Recruiters: IDEAYA's Non-Solicitation Policy strictly prohibits agencies and recruiters from any contact and communication with IDEAYA employees, managers, and leaders to submit unsolicited candidate resumes and/or to solicit business partnerships.
Director, Clinical Scientists Denali Therapeutics IncDirector, Clinical ScientistsSouth San Francisco, CA$272,000–$336,000 / yearKey Accountabilities / Core Job Responsibilities: Lead clinical team in new therapeutic areas or highly complex projects including the development of multiple, complex clinical protocols, informed consents, and other study materials. Denali is founded on the collaboration of leading scientists, industry experts, and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
Director, Clinical Scientists Denali TherapeuticsDirector, Clinical ScientistsSouth San Francisco, CA$272,000–$336,000 / yearKey Accountabilities / Core Job Responsibilities: Lead clinical team in new therapeutic areas or highly complex projects including the development of multiple, complex clinical protocols, informed consents, and other study materials. Denali is founded on the collaboration of leading scientists, industry experts, and investors who share the vision that scientific discovery energetically applied to translational medicine is the key to delivering effective therapies to patients.
Associate Director, Clinical Supply Planning Cytokinetics IncAssociate Director, Clinical Supply PlanningSouth San Francisco, CA$195,390–$227,955 / yearThe Associate Director, Clinical Supply Chain, will develop and formulate supply chain strategies, meet project deliverables, solve business problems and drive improvements within Global Clinical Supply Chain (GCSC), as well as the Cytokinetics enterprise. Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction.
Director, Clinical Operations Study Start-Up Summit TherapeuticsDirector, Clinical Operations Study Start-UpPalo Alto, California$203,000–$253,000 / yearRequires minimum of 15+ years of experience in the biotech/pharmaceutical industry with direct experience in feasibility, study start-up, site activation for global Phase 3 clinical trials, development of Master and country level ICFs, site payments, eTMF, CTMS, vendor oversight, and inspection readiness with a strong understanding of global regulatory requirements and clinical operations, and with over 5 years of supervisory/management experience. HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
Director, Clinical Operations Study Start-Up Summit Therapeutics plcDirector, Clinical Operations Study Start-UpPalo Alto, CA$203,000–$253,000 / yearRequires minimum of 15+ years of experience in the biotech/pharmaceutical industry with direct experience in feasibility, study start-up, site activation for global Phase 3 clinical trials, development of Master and country level ICFs, site payments, eTMF, CTMS, vendor oversight, and inspection readiness with a strong understanding of global regulatory requirements and clinical operations, and with over 5 years of supervisory/management experience. HARMONi: Phase 3 clinical study which was intended to evaluate ivonescimab combined with chemotherapy compared to placebo plus chemotherapy in patients with EGFR-mutated, locally advanced or metastatic non-squamous NSCLC who were previously treated with a 3rd generation EGFR TKI.
Clinical Sciences Associate Director (Multiple Listings) Novartis AGClinical Sciences Associate Director (Multiple Listings)San Carlos, CA$152,600–$283,400 / yearLead the ongoing medical/scientific review of clinical trial data across assigned studies in collaboration with the medical expert and key line functions, and partners on data analysis and data interpretation, including safety trend analysis, signal detection, development of first interpretable results, reporting clinical study results in Clinical Study Report (CSR), and internal/external publications. Essential Requirements: Bachelors in life science/healthcare required; Advanced degree or equivalent education/degree in life sciences/ healthcare preferred (PhD/MD/PharmD/ Masters).8+ years' experience in clinical trials/development.
Senior Director, Clinical Operations BigHat BiosciencesSenior Director, Clinical OperationsSan Mateo, CaliforniaClinical Document Generation: Manage the preparation and lifecycle of key clinical documents, including protocols, informed consent forms, investigator brochures, clinical study reports, and regulatory submissions, ensuring accuracy, timeliness, and compliance with applicable guidelines. Translational Biomarker Support: Partner closely with the Translational Biomarker team to ensure clinical operations infrastructure supports biomarker sample collection, handling, and logistics across all trial sites.